O‘PKANING SURUNKALI OBSTRUKTIV KASALLIGI: ZAMONAVIY TUSHUNCHA, EPIDEMIOLOGIYA VA XAVF OMILLARI

Authors

  • Zokirov Husanboy Ikromjon oʻgʻli CAMU xalqaro tibbiyot universiteti magistranti
  • Musayev Farxod Tahirovich Ilmiy rahbar: PhD

Keywords:

SO‘OK, epidemiologiya, xavf omillari, spirometriya, chekish, biomass, havo ifloslanishi.

Abstract

Surunkali obstruktiv o‘pka kasalligi (SO‘OK) uzoq davom etuvchi respirator simptomlar va havo oqimining to‘liq qaytmas cheklanishi bilan kechuvchi, heterogen, oldini olish hamda davolash mumkin bo‘lgan kasallikdir. Zamonaviy yondashuvda u faqat chekish bilan bog‘liq kasallik sifatida emas, balki hayot davomida shakllanuvchi “life-course” va “exposome” omillari bilan bog‘liq tizimli kasallik sifatida qaraladi. 2026-yilgi WHO ma’lumotiga ko‘ra, SO‘OK dunyoda o‘limning uchinchi sababi bo‘lib, 2023-yilda 3,4 million o‘limga olib kelgan; 70 yoshdan kichik o‘limlarning qariyb 90 foizi past va o‘rta daromadli mamlakatlarda qayd etiladi. 40 yoshdan katta aholida global tarqalish diagnostik mezonga qarab sezilarli farq qiladi: fixed ratio bo‘yicha 12,64%, LLN bo‘yicha 7,38% deb baholangan. (World Health Organization)

References

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report. 2025.

World Health Organization. Chronic obstructive pulmonary disease (COPD). Fact sheet. 2026.

Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242.

Stolz D, Mkorombindo T, Schumann DM, et al. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022;400(10356):921–972.

Adeloye D, et al. Global, regional, and national prevalence of, and risk factors for, COPD in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022.

Al Wachami N, et al. Estimating the global prevalence of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Public Health. 2024.

de Oca MM, et al. The global burden of COPD: epidemiology and effect of prevention strategies. 2025.

Centers for Disease Control and Prevention. Products - Data Briefs - Number 529: COPD prevalence in adults, 2023. 2025.

Kanchustambham V, Brown BD. Chronic Obstructive Pulmonary Disease (COPD). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.

Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022;10(5):497–511.

Pando-Sandoval A, et al. Risk factors for chronic obstructive pulmonary disease in never-smokers: a systematic review. Chronic Respiratory Disease. 2022.

Hu G, et al. Risk of COPD from exposure to biomass smoke: a meta-analysis. Chest. 2010.

Capistrano SJ, et al. Evidence of Biomass Smoke Exposure as a Causative Factor for COPD and Its Clinical Characteristics. 2017.

Kamal R, Srivastava AK, Kesavachandran CN, et al. Chronic obstructive pulmonary disease in women due to indoor biomass burning: a meta-analysis. Int J Environ Health Res. 2022;32(6):1403–1417.

Sin DD, et al. Air pollution and COPD: GOLD 2023 committee report. 2023.

Murgia N, et al. Occupational COPD—The most under-recognized occupational lung disease? 2022.

Bongers Q, et al. Impact of occupational exposures in patients with chronic obstructive pulmonary disease. 2025.

Sritharan J, et al. Risk of chronic obstructive pulmonary disease in a large cohort exposed to vapours, gases, dusts, and fumes. Scientific Reports. 2024.

Stoller JK. Alpha-1 Antitrypsin Deficiency. GeneReviews [Internet]. 2023.

Meseeha M, et al. Alpha-1 Antitrypsin Deficiency. StatPearls [Internet]. 2024.

Fan H, et al. Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis. 2021.

Gai X, et al. Advances in the awareness of tuberculosis-associated chronic obstructive pulmonary disease. 2024.

Liao KM, et al. The Risk of Tuberculosis in Chronic Obstructive Pulmonary Disease. 2025.

Duan P, et al. Impact of early life exposures on COPD in adulthood. 2021.

Hopkinson NS, et al. Early Life Exposures and the Development of Chronic Obstructive Pulmonary Disease across the Life Course. 2024.

Luo P, et al. Association between birth weight and chronic obstructive pulmonary disease in the UK Biobank: a prospective cohort study. 2024.

Lee H, et al. Impact of socioeconomic status on chronic obstructive pulmonary disease. 2025.

Liu S, et al. Associations of socioeconomic status and health lifestyles with chronic obstructive pulmonary disease: two nationwide population-based studies. BMC Public Health. 2025;25:2310.

Chung C, et al. Association between body mass index and chronic obstructive pulmonary disease in young individuals: a nationwide population-based cohort study. Scientific Reports. 2024.

Czarnota P, et al. Sex Differences in Chronic Obstructive Pulmonary Disease. 2025.

Downloads

Published

2026-08-05

How to Cite

Zokirov Husanboy Ikromjon oʻgʻli, & Musayev Farxod Tahirovich. (2026). O‘PKANING SURUNKALI OBSTRUKTIV KASALLIGI: ZAMONAVIY TUSHUNCHA, EPIDEMIOLOGIYA VA XAVF OMILLARI. IQRO , 23(01), 54–58. Retrieved from https://www.wordlyknowledge.uz/index.php/iqro/article/view/8807